Top Gap Ups and Downs on Wednesday: HMY, GFI, GMAB, A and More
Agilent to Announce Fourth-Quarter Fiscal Year 2024 Financial Results on Nov. 25
Bernstein Adjusts Agilent Technologies Price Target to $140 From $130, Maintains Market Perform Rating
Agilent Partners With NUS to Advance Cardiovascular Research in Singapore
Agilent Is Maintained at Underweight by Barclays
(A) - Analyzing Agilent Technologies's Short Interest
Barclays Adjusts Price Target on Agilent Technologies to $145 From $135
$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
Australia & New Zealand Research Antibodies Market Report 2024-2030, With Leading Players Abcam, BD, Merck, Lonza, Cell Signaling Technology, F. Hoffmann-La Roche, Agilent Technologies, Revvity & More
Citi Maintains Agilent Technologies(A.US) With Buy Rating, Maintains Target Price $165
Single-cell Technologies Research Report 2023-2024 & 2029 10x Genomics, Agilent Technologies, BD, Bio-Rad Laboratories, Danaher, Illumina, Merck, Promega, Qiagen, & Thermo Fisher Scientific - ResearchAndMarkets.com
Do Options Traders Know Something About Agilent Technologies (A) Stock We Don't?
Catalyst Watch: Tesla's Robotaxi Reveal, AI Events for Nvidia, AMD, and HP Enterprise
Protein Expression Market Global Report 2024, With Benchmarking of Key Players Agilent Technologies, Ajinomoto Bio-Pharma Services, GenScript Biotech, Lonza, Merck, QIAGEN, Sartorius, & WuXi Biologics - ResearchAndMarkets.com
Estimating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
Biopharmaceutical Processing Equipment and Consumables Research Report 2024 - Global Forecast to 2031 With Market Share Analysis of Danaher, Thermo Fisher Scientific, Sartorius, & Agilent Technologies - ResearchAndMarkets.com
Express News | Agilent Technologies Inc : BofA Global Research Raises Price Objective to $153 From $147
Agilent Is Maintained at In-Line by Evercore ISI Group
Agilent Technologies Analyst Ratings
Evercore ISI Adjusts Price Target on Agilent Technologies to $145 From $135